@article{oai:repository.lib.tottori-u.ac.jp:00004869,
 author = {Taniguchi, Fuminori and Taniguchi, Fuminori and Enatsu, Akiko and Ikebuchi, Ai and Yamane, Emiko and Moriyama, Maako and Murakami, Jiro and Harada, Takashi and Harada, Takashi and Harada, Tasuku and Harada, Tasuku and Enatsu, Akiko and Ikebuchi, Ai and Yamane, Emiko and Moriyama, Maako and Murakami, Jiro},
 issue = {3},
 journal = {Yonago Acta Medica, Yonago Acta Medica},
 month = {Sep},
 note = {Endometriosis is a chronic inflammatory disorder associated with pelvic pain and infertility. Because surgical and medical therapies control symptoms, but it is hard to cure completely endometriosis, long term of pharmacologic management is necessary. Norethisterone (NET), one of progestins, has safety profile and advantage that allow long-term use. In this preliminary report, we showed the efficacy of NET in 6 patients with endometriosis. The size of ovarian endometrioma was decreased after treatment with NET for 6 months, and all patients were relieved from dysmenorrhea pain within 6 months, suggesting that NET would be a suitable medication to treat endometriosis.},
 pages = {182--185},
 title = {Efficacy of Norethisterone in Patients with Ovarian Endometrioma},
 volume = {60},
 year = {2017}
}